ESMO 2023 BioNTech Data slide image

ESMO 2023 BioNTech Data

_4 BNT221 Safety and efficacy of BNT221, a non-engineered neoantigen specific T cell product for adoptive cell therapy of metastatic melanoma BIONTECH
View entire presentation